Database for Interstitial Lung Disease

Medical University of Graz412 enrolled

Overview

The purpose of this study is to establish a clinical database for patients bearing at risk for ILD (Interstitial Lung Disease) and to set up a prospective ILD Screening program for these patients.

Study Type

OBSERVATIONAL

Enrollment

412

Conditions

Lung Diseases, Interstitial

Interventions

chest CTDIAGNOSTIC_TEST

assessment of interstitial lung disease using chest CT

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Age: ≥ 18 years * patients with a known systemic disease bearing a risk for ILD * signed informed consent (for prospective part) Exclusion Criteria: * Age \< 18 years * comorbidities severely limiting life-expectancy (e.g. severe cardiovascular conditions, malignant disease)

Locations (1)

Medical University of Graz, Department of Internal Medicine, Division of Pulmonology

Graz, Austria

RECRUITING

Outcomes

Primary Outcomes

DLCO%pred (carbon monoxide diffusing capacity) at time of ILD diagnosis

The investigators aim to assess DLCO% pred at time of ILD diagnosis in patients undergoing a ILD Screening algorithm and compare to the retrospective patient cohort with diagnosed ILD and the DLCO%pred at time of ILD diagnosis

Time frame: 5 years

Secondary Outcomes

FVC%pred (Forced vital capacity) at time of ILD diagnosis

The investigators aim to assess FVC% pred at time of ILD diagnosis in patients undergoing a ILD Screening algorithm and compare to the retrospective patient cohort with diagnosed ILD and the FVC%pred at time of ILD diagnosis

Time frame: 5 years

Central Contacts

Gabor Kovacs, MD

CONTACT

+43-316-385 gabor.kovacs@klinikum-graz.at

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.